Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Categories for... Drug Discovery

Drug Discovery Therapeutic Areas

Sygnature Discovery’s medicinal chemists design improved agents against RSV infection

READ ARTICLE

Drug Discovery

Unlocking efficiency in drug discovery: GE Healthcare’s The Pulse visits Sygnature Discovery

READ ARTICLE

Drug Discovery

Sygnature Discovery enhances Biophysics capability with addition of Biacore 8K SPR system

READ ARTICLE

Drug Discovery

Double celebration for TopiVert and Sygnature Discovery as two drug candidates begin clinical trials

READ ARTICLE

Drug Discovery Therapeutic Areas

Sygnature Discovery, Mironid®, and Peak Proteins to collaborate to discover new therapies for life-threatening and currently incurable kidney disease, ADPKD

READ ARTICLE

Drug Discovery

Pelago Bioscience and Sygnature Discovery collaborate to Provide CETSA® based Target Engagement Assays

READ ARTICLE

Drug Discovery

Sygnature is exhibiting at ELRIG’s Drug Discovery 2016 event at the ACC, Liverpool. Stand G1

READ ARTICLE

Drug Discovery Therapeutic Areas

Sygnature Discovery and Viramatix announce anti-viral drug discovery strategic alliance

READ ARTICLE

Drug Discovery

Sygnature Discovery’s drug discovery capabilities enhanced by acquisition of BMG LABTECH PHERAstar® FSX

READ ARTICLE

Drug Discovery

Adoption of the ImageXpress® Micro Confocal High-Content Imaging System enhances Sygnature Discovery’s Capabilities

READ ARTICLE

Drug Discovery

Adoption of IncuCyte® ZOOM enhances Sygnature Discovery’s Capabilities

READ ARTICLE

Drug Discovery

Sygnature Discovery and RenaSci Establish Strategic Alliance focused on Metabolic and CNS Disorders

READ ARTICLE